Assis, Rahyza I F <br/><br/>
RG108 increases NANOG and OCT4 in bone marrow-derived mesenchymal cells through global changes in DNA modifications and epigenetic activation.  [electronic resource] 

 -  PloS one  2018 
 - e0207873 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0207873  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Biomarkers--metabolism<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>DNA (Cytosine-5-)-Methyltransferase 1--genetics<br/>DNA Methylation--drug effects<br/>Endoglin--metabolism<br/>Epigenesis, Genetic--drug effects<br/>Humans<br/>Mesenchymal Stem Cells--drug effects<br/>Mixed Function Oxygenases--genetics<br/>Nanog Homeobox Protein--genetics<br/>Octamer Transcription Factor-3--genetics<br/>Phthalimides--pharmacology<br/>Promoter Regions, Genetic--drug effects<br/>Proto-Oncogene Proteins--genetics<br/>RNA, Messenger--genetics<br/>Tryptophan--analogs & derivatives